Polyphor

Switzerland
Biotech

Spexis narrows focus to keep lights on into 2023

With the ink barely dry on the merger that created it, the Swiss biotech is narrowing focus to stretch its cash runway out to January 2023.
Nick Paul Taylor Jul 28, 2022 8:45am
ax in a tree stump

Polyphor to lay off staff, shutter failed breast cancer phase 3

Jul 16, 2021 8:15am
Breast Cancer Cells

Polyphor flops a phase 3, jeopardizing its future

Jun 28, 2021 7:05am
A patient with a surgical mask looks out a window

Polyphor's breast cancer candidate shows promise in COVID-19

Jun 7, 2021 8:30am
Human Neutrophil Elastase

Santhera, reeling from DMD blow, lands cystic fibrosis drug

Feb 15, 2018 8:50am